Maintenance and reliever therapy (MART) is a combined treatment system for asthma where a single, combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers.
Taxonomy: 15 minutes, Asthma, Clinical resource or information, Current, Inhaler devices, Standard, Advanced, PCRS Produced / Collaboration, Expert
Now is the time to make MART moves for asthma.
Taxonomy: 15 minutes, Asthma, Clinical resource or information, Current, Inhaler devices, Standard, Advanced, PCRS Produced / Collaboration, Expert
Maintenance and reliever therapy (MART) is a treatment for asthma where a single combined inhaler is used for both maintenance and reliever purposes, instead of having separate preventer (brown) and reliever (blue) inhalers.
Taxonomy: Clinical resource or information, Current, Other, 30 minutes, PCRS Produced / Collaboration
A new interactive resource to facilitate the delivery of holistic care.Thi
Taxonomy: 15 minutes, Asthma, Clinical resource or information, Current, Respiratory tests and investigations, PCRS Produced / Collaboration
In this article, the authors review evidence, guidance and current practice to provide a consensus approach to calculating and interpreting peak expiratory flow rate (PEFR) variability and reversibility from peak flow diary recordings for asthma diagnosis.
Taxonomy: 15 minutes, Clinical resource or information, COPD, Current, PCRU
In this article the authors review current evidence and guidance for the treatment of Chronic obstructive pulmonary disease (COPD) in order to bring up to date the Primary Care Respiratory Society (PCRS) consensus approach and algorithm first published in 2017 known as ‘Keeping it Simple’.
Taxonomy: 15 minutes, Asthma, Clinical resource or information, Current, PCRU, PCRS Produced / Collaboration
In 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved the use of a dual (Inhaled corticosteroid/ Formoterol) combination treatment to be used as a reliever therapy for people aged 12 and over with the therapy choice situated early in the asthma treatment pathway as an a
Taxonomy: Clinical resource or information, Current, Other organisation/charity produced, Respiratory tests and investigations, 30 minutes
NICE Diagnostic Guidance 12 (DG12); Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath.
Taxonomy: Clinical resource or information, Current, Other organisation/charity produced, Respiratory tests and investigations, 1 hour
NICE guidance is integral to the clinical care that we offer as Health Care Professionals (HCPs).
Taxonomy: 15 minutes, Clinical resource or information, Current, Other organisation/charity produced, Respiratory tests and investigations, Standard
accuRx has created a FeNO template to send to patients prior to their appointment via text message. For information on what's included and how to find the template, have a look at the guidance document below.
Taxonomy: Clinical resource or information, Current, Health inequalities, Other organisation/charity produced, Respiratory tests and investigations, Standard, 30 minutes
This may include an understanding of the benefits of having a FeNO test, including:
Taxonomy: Clinical resource or information, Current, Other organisation/charity produced, Respiratory tests and investigations, 30 minutes, Advanced
These templates are only available to EMIS and TPP users – they are not available to MicroTest and Vision users.
Taxonomy: Asthma, Clinical resource or information, Current, Other organisation/charity produced, Respiratory tests and investigations, 1 hour
The AHSN Network supported the spread of FeNO testing across primary care in England from April 2021 to March 2023, led by Wessex AHSN as the lead AHSN. This programme was delivered as part of the NHS England Accelerated Access Collaborative Rapid Uptake Programme.
Taxonomy: Clinical resource or information, COPD, Current, Respiratory tests and investigations, Service development and improvement
The one-minute sit to stand test (1-MSTST) has become the test of choice during the pandemic for measuring exercise capacity, both at in-person and virtual appointments due to the inability to conduct robust six minute or incremental / endurance shuttle walk tests (6MWT/ ISWT/ ESWT).
Taxonomy: 15 minutes, Clinical resource or information, Current, Infection, PCRU, PCRS Produced / Collaboration
Non-tuberculous mycobacteria (NTM) are a group of bacteria that are capable of causing opportunistic lung infections and the development of NTM pulmonary disease (NTM-PD).